Introduction: Cytokine storm control is the main target for improving severe COVID-19 by using immunosuppressive treatment. Effective renal replacement therapy (RRT) could give us an advantage removing cytokines in patients with RRT requirements superimposed on COVID-19. Methods: This is a prospective observational study in COVID-19 patients who required hemodialysis (HD). Patients were assigned to online hemodiafiltration (OL-HDF) and expanded HD (HDx) according to Brescia group recommendations. We measured several cytokines, β2 microglobulin and albumin levels pre/post-dialysis and on 1st–2nd week. We compared levels among both techniques and control group (HD without COVID-19). Results: We included 26 patients: 18 with COVID-19 on RRT (5 of them had acute kidney injury [AKI]) and 8 controls. We confirm higher cytokine levels in COVID-19 patients than controls and even higher in patients with AKI than in those with chronic kidney disease. Most cytokines raised during HD session, except IL-10 and TNFα. IL-10 was eliminated by any dialysis technique, while clearance of TNFα was higher in the HDx group. HDx achieved a deeper normalization of cytokines and β2 microglobulin reduction. Mortality was higher in the OL-HDF group than the HDx group. Discussion: Not all cytokines behave equally along HD session. The following characteristics should be taken into account, such as intrinsic kinetic profile during a HD session. HDx seems to get better performance, probably due to the combination of different factors; however, we did not reach statistical significance due to the small sample size, dropout, and reduction of AKI incidence during the 2nd pandemic wave. Conclusion: HDx appears to provide better clearance for TNFα and β2 microglobulin during HD session and associates lower mortality. We propose the HDx technique for COVID-19 patients with RRT requirements since it seems to be safe and more effective than OL-HDF. Further studies are still needed, but we hope that our preliminary data may help us in future pandemic waves of SARS-CoV-2 or other viruses still to come.

1.
Ministerio de Sanidad
;
Gobierno de España
.
Actualización no 380. Enfermedad por el coronavirus (COVID-19)
.
2021
. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actualizacion_380_COVID-19.pdf. Accessed 2021 May.
2.
Guan
WJ
,
Ni
ZY
,
Hu
Y
,
Liang
WH
,
Ou
CQ
,
He
JX
,
Clinical characteristics of coronavirus disease 2019 in China
.
N Engl J Med
.
2020
;
382
:
1708
20
.
3.
Portolés
J
,
Marques
M
,
López-Sánchez
P
,
De Valdenebro
M
,
Muñez
E
,
Serrano
ML
,
Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak
.
NDT
.
2020 Aug
;
35
(
8
):
1353
61
.
4.
Ye
Q
,
Wang
B
,
Mao
J
.
The pathogenesis and treatment of the “Cytokine Storm” in COVID-19
.
J Infect
.
2020
;
80
(
6
):
607
13
. .
5.
Chen
G
,
Wu
D
,
Guo
W
,
Cao
Y
,
Huang
D
,
Wang
H
,
Clinical and immunological features of severe and moderate coronavirus disease 2019
.
J Clin Invest
.
2020 May 1
;
130
(
5
):
2620
9
.
6.
Lucas
C
,
Wong
P
,
Klein
J
,
Castro
TBR
,
Silva
J
,
Sundaram
M
,
Longitudinal analyses reveal inmunological misfiring in severe COVID19
.
Nature
.
2020 Aug
;
584
:
463
9
.
7.
Mahmudpour
M
,
Roozbeg
J
,
Keshavarz
M
,
Farrokhi
S
.
COVID 19 cytokine storm: the anger of inflammation
.
Cytokine
.
2020
;
133
:
155151
.
8.
Rabb
H
,
Griffin
M
,
McKay
D
,
Swaminathan
S
,
Pickkers
P
,
Rosner
M
,
Inflammation in AKI: current understanding, key questions, and knowledge gaps
.
J Am Soc Nephrol
.
2016
(
27
):
371
9
.
9.
Lee
DW
,
Faubel
S
,
Edelstein
CL
.
Cytokines in acute kidney injury (AKI)
.
Clin Nephrol
.
2011
;
76
(
76
):
165
73
. .
10.
World Health Organization
.
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
.
2020
. Available from: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf. Accessed 2021 Mar.
11.
Batlle
D
,
Soler
MJ
,
Sparks
M
,
Hiremath
S
,
South
A
,
Welling
P
,
Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology
.
JASN
.
2020
;
31
:
1380
3
.
12.
Durvasula
R
,
Wellington
T
,
McNamara
E
,
Watnick
S
.
COVID-19 and kidney failure in the acute care setting: our experience from seattle
.
Am J Kidney Dis
.
2020
;
76
(
1
):
4
6
. .
13.
Tarragón
B
,
Valdenebro
M
,
Serrano
ML
,
Maroto
A
,
Llópez-Carratalá
MR
,
Ramos
A
,
Acute kidney failure in patients admitted due to COVID-19
.
Nefrologia
.
2021
;
41
(
1
):
34
40
.
14.
Alberici
F
,
Delbarba
E
,
Manenti
C
,
Econimo
L
,
Valerio
F
,
Pola
A
,
Management of patients on dialysis and with kidney transplant during Covid- 19 coronavirus infection
.
Brescia Ren Covid Task Force
.
2020
:
1
15
.
15.
Ronco
C
,
Reis
T
.
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
.
Nat Rev Nephrol
.
2020
;
16
:
308
10
. .
16.
Maduell
F
,
Moreso
F
,
Pons
M
,
Ramos
R
,
Mora-Macià
J
,
Carreras
J
,
High efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients
.
J Am Soc Nephrol
.
2013 Feb 28
;
24
(
3
):
487
97
.
17.
Ronco
C
,
Marchionna
N
,
Brendolan
A
,
Neri
M
,
Lorenzin
A
,
Martínez Rueda
AJ
.
Expanded haemodialysis: from operational mechanism to clinical results
.
Nephrol Dial Transplant
.
2018
;
33
:
iii41
7
. .
18.
Ronco
C
,
Marchionna
N
,
Brendolan
A
,
Neri
M
,
Lorenzin
A
,
Martínez Rueda
AJ
.
Expanded haemodialysis: from operational mechanism to clinical results
.
Nephrol Dial Transplant
.
2018
;
33
:
iii41
7
. .
19.
Perez-Garcia
R
,
Alcazar-Arroyo
R
,
De Sequera Ortiz
P
.
Cuál es el papel de la hemodialisis extendida en el tratamiento sustitutivo renal en 2020?
Nefrologia
.
2021
;
41
(
3
):
227
36
.
20.
Kim
YG
,
Moon
H
,
Kim
SY
,
Lee
YH
,
Jeong
DW
,
Kim
K
,
Inevitable isolation and the change of stress markers in hemodialysis patients during the 2015 MERS-CoV outbreak in Korea
.
Sci Rep
.
2019 Dec 1
;
9
(
1
):
5676
.
21.
Chen
LX
,
Demirjian
S
,
Udani
SM
,
Trevino
SA
,
Murray
PT
,
Koyner
JL
.
Cytokine clearances in critically ill patients on continuous renal replacement therapy
.
Blood Purif
.
2018 Oct 1
;
46
(
4
):
315
22
. .
22.
Valga
F
,
Vega-Diaz
N
,
Monzon
T
,
Gonzalez-Cabrera
F
,
Santana
A
,
Baamonde
E
,
Role of extended hemodialysis in COVID-19: a case report
.
Nefrologia
.
2020
;
40
:
488
90
.
23.
Borish
LC
,
Steinke
JW
.
2. Cytokines and chemokines
.
J Allergy Clin Immunol
.
2003
;
111
(
2
):
S460
75
. .
24.
Kelso
A
.
Cytokines: principles and prospects
.
Immunol Cell Biol
.
1998
;
76
(
4
):
300
17
. .
25.
Hoffman
U
,
Fischereder
M
,
Marx
M
,
Schweda
F
,
Lang
B
,
Straub
R
,
Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material?
Am J Nephrol
.
2003
;
23
(
6
):
442
7
.
26.
Lonnemann
G
,
Haubitz
M
,
Schindler
R
.
Hemodialysis-associated induction of cytokines
.
Blood PurifVolumen
.
1990
;
8
(
4
):
214
22
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.